Mary K. Stamatakis, Pharm.D.

Associate Dean for Academic Affairs and Educational Innovation and Associate Professor of Clinical Pharmacy

Department of Clinical Pharmacy
West Virginia University School of Pharmacy
1136 Health Sciences North
P.O. Box 9500
Morgantown, WV 26506-9520

Phone: (304)293.1466
Fax: (304)293.5483
E-Mail: mstamatakis@hsc.wvu.edu
Link to Full CV - PDF

BIOSKETCH

Mary Stamatakis serves as Associate Dean for Academic Affairs and Educational Innovation and Associate Professor at the West Virginia University School of Pharmacy. In this capacity, she oversees the professional degree program, manages the continued accreditation of the program, and directs faculty development, student and faculty awards and recognition, and School of Pharmacy committee activities. Serving as a member of the School’s Executive Committee, she works closely with the administrative team within the school to develop and implement School of Pharmacy policy and procedures. She previously served as a member of the Department of Clinical Pharmacy Management Team at West Virginia University for two and a half years.

She has served on numerous school and university committees during her twelve years at WVU, including serving as chair of the school’s curriculum committee from 1999 to 2006 and as a member of the school’s assessment committee since 1999. She has also provided service to the university community as a member of the University’s Faculty Senate for six years and as an elected representative to the Faculty Senate’s executive committee in 2003. During the past two years, she has chaired AACP’s Pharmacy Practice Educational Outcomes Task Force to develop educational outcomes to supplement the 2004 CAPE outcomes. She also serves as a team member for Accreditation Council for Pharmacy Education site visits.

Her teaching interests include nephrology pharmacotherapy and mentorship of students and residents for careers in teaching and administration.

She earned a Bachelor of Science in Pharmacy and a Doctor of Pharmacy from The Ohio State University and completed a nephrology specialty residency at OSU Hospitals.

EDUCATION

Nephrology Specialty Residency, The Ohio State University Medical Center (1993)
The Ohio State University, Pharm.D. (1992)
The Ohio State University, B.S. Pharm. (1989)

TEACHING INTERESTS AND COURSES TAUGHT

PHAR 723, Pharmaceutical Care Lab 3 : (course coordinator and faculty instructor); required course for second year Doctor of Pharmacy students

PHAR 730, Pathophysiology/Therapeutics 4 : (nephrology section coordinator and instructor); required course for third year Doctor of Pharmacy students

PHAR 724, Pharmaceutical Care Lab 4: (laboratory instructor); required course for first year Doctor of Pharmacy students

Advanced Clinical Pharmacokinetics, Practicum 3, Practicum 4 (guest instructor)

Teaching Experiential Rotation, Administration Experiential Rotation for fourth year Doctor of Pharmacy students

PRACTICE INTERESTS

Kidney disease and dialysis

RESEARCH AND SCHOLARSHIP INTERESTS

Pharmacy education
Drug dosing in kidney disease
Disintegration/dissolution of nutritional supplements.

SELECTED PUBLICATIONS

Stamatakis MK. Acute renal failure. In: Pharmacotherapy Principles and Practice, 1 st edition. Chisholm M, Schwinghammer TL, Wells BG, DiPiro JT, Kolesar JM, and Malone PM. McGraw Hill Companies, Inc. New York, NY, 2007.

Kidd RS, Stamatakis MK. Comparison of students’ performance and satisfaction of a clinical pharmacokinetics course delivered live and by interactive videoconferencing. Am J Pharm Educ 2006;70(1): Article 10.

Stamatakis MK. Chronic kidney disease. In: Drug-Induced Diseases: Prevention, Detection, and Management. J Tisdale, D Miller (eds). American Society of Health-System Pharmacists, Bethesda, MD, 2005.

Slain D, Abate M, Hodges BM, Stamatakis MK, Wolak S. An interactive response system to promote active learning in the doctor of pharmacy curriculum. Am J Pharm Educ 2004;68: Article 117.

Stamatakis MK, Schreiber JM, Slain D, Gunel E. Vancomycin administration during dialysis with low-flux polysulfone membranes: traditional versus a supplemental dosage regimen. Am J Health-Syst Pharm 2003;60:1564-8.

Abate MA, Stout PJ, Stamatakis MK, Gannett PM, Dunsworth TS. Development and evaluation of computerized problem-based learning cases emphasizing basic sciences concepts. Am J Pharm Educ 2000;64(1):74-82.

Stamatakis MK, Meyer-Stout PJ. Disintegration performance of renal multivitamin supplements. J Renal Nutr 1999;9(2):78-83

Stamatakis MK, Leader WG, Tracy TS. Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions. Am J Health-Syst Pharm 1999;56(3):246-8

Stamatakis MK, Alderman JM, Meyer-Stout PJ. Effect of pH on in vitro disintegration of phosphate binders. Am J Kidney Dis 1998;32(5):808-12.